Myovant Sciences Ltd. (MYOV) Stock: Is This Biotechnology Stock Worth Your Consideration?

0

Myovant Sciences Ltd. (MYOV) is gaining in the market in today’s trading session. The company, focused on the biotechnology space, is currently priced at $7.83 after heading up 11.86% so far in today’s session. When it comes to biotech companies, there are several factors that have the ability to cause gains in the market. News is one of the most common reasons for movement. Here are the most recent headlines centered around MYOV:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-06-19 04:05PM Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for First Fiscal Quarter Ended June 30, 2019
Aug-05-19 06:00AM Myovant Sciences- Progress in Women’s Health
Jul-23-19 05:36PM CEO calls it an ‘important day for women’s health.’ Wall Street appears unimpressed
07:30AM Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and Positive Results from Bioequivalence Study
Jul-22-19 04:01PM Myovant Sciences to Host Webcast and Conference Call at 8:30 a.m. Eastern Time Tuesday, July 23rd to Discuss Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and from Bioequivalence Study

However, when making a decision with regard to investing, prospective investors should look into far more than news, this is especially the case in the generally speculative biotechnology sector. Here’s what’s going on with Myovant Sciences Ltd..

Recent Movement From MYOV

While a move up on a single session, like the gain that we’re seeing from Myovant Sciences Ltd. might cause excitement in some investors, a single session move by itself shouldn’t be the reason for a decision to, or not to, invest in a company. It’s generally important to take a look at trends beyond a single trading session. In the case of MYOV, here are the movements that investors have experienced:

  • Past 7 Days – Throughout the past five trading sessions, MYOV has generated a change in price in the amount of -6.54%.
  • Past Month – The return from Myovant Sciences Ltd. over the past month has been -19.26%.
  • Past Quarter – Throughout the last three months, the stock has produced a return that comes to -43.91%
  • Past 6 Months – Throughout the previous 6 months, we have seen a performance that amounts to -67.15% from the company.
  • YTD – Since the the first trading session of this year MYOV has produced a return of -57.34%.
  • Full Year – Lastly, in the past year, we have seen performance of -66.73% out of MYOV. Over this period of time, the stock has traded at a high of -71.48% and a low price of 18.64%.

Ratios To Watch

Looking at various ratios associated with a stock can give traders a look of how risky and/or potentially profitable a pick may be. Below are a few of the key ratios to look at when looking at MYOV.

Short Ratio – The short ratio is a measure of short interest. As the short ratio heads up, it means that more investors believe that the value of the stock is going to fall. Across the sector, biotech stocks can come with a higher short ratio. On the other hand, we tend to see a lot of short squeezes in the space. Nonetheless, in regard to Myovant Sciences Ltd., the stock’s short ratio comes to 7.99.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Essentially, they measure whether or not a company can pay for its debts when they come due based on current assets or quick assets. In the biotech sector, several companies are heavily reliant on the continuation of support from investors, these ratios can seem bad. Nonetheless, quite a few gems in the biotech space come with great current and quick ratios. When it comes to MYOV, the quick and current ratios work out to 3.40 and 3.40 respectively.  

Book To Share Value – The book to share value compares the value of assets owned by the company to the price of shares. In this case, the book to share value ratio works out to 1.04.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the value of shares. Many early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to look into. In the case of MYOV, the cash to share value ratio is 2.53.

How Analysts Feel About Myovant Sciences Ltd.

Although it’s rarely a good idea to avoid doing your DD and blindly following the thoughts of analysts, it is a good idea to use their analysis to validate your own opinions before making investment decisions in the biotechnology space. Here are the most recent moves that we have seen from analysts with regard to MYOV.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-19-19 Initiated SVB Leerink Outperform
May-30-19 Resumed Citigroup Buy
Apr-12-19 Initiated Evercore ISI Outperform
Feb-13-19 Upgrade Barclays Equal Weight → Overweight $22 → $25
Oct-26-18 Initiated Goldman Neutral $25

Is Big Money Interested In Myovant Sciences Ltd.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in MYOV, here’s what we’re seeing:

Institutions own 38.80% of the company. Institutional interest has moved by 48.01% over the past three months. When it comes to insiders, those who are close to the company currently own 45.50% percent of MYOV shares. Institutions have seen ownership changes of an accumulative 90.79% over the last three months.

How Many Shares Of MYOV Are Available?

Traders and investors tend to be interested in the amounts of shares both available and outstanding. In terms of Myovant Sciences Ltd., currently there are 89.63M and there is a float of 36.22M. This means that of the total of 89.63M shares of MYOV in existence today, 36.22M are able to trade hands in the public space.

It’s also important to pay attention to the short float. Think about it, when a large percentage of the float available for trading is shorted, the overall feeling in the market is that the company is headed for a deep dive. With regard to MYOV, the percentage of the float that is shorted is 7.34%. Most traders believe that a concerning short percent of the float is any percentage over 40%. However, I have seen that any short ratio over 26% is generally a risky play.

Earnings

What have ween seen from MYOV in terms of financial results?Here’s the information:

  • Analyst Expectations – As it stands at the moment, Wall Street analysts have expectations that MYOV will create earnings per diluted share that comes to -2.87, with -0.98 to be announced in the report for the current quarter. Although this information isn’t associated with earnings, because we’re talking on the topic of analysts, MYOV is presently rated a 1.70 on a scale from 1 to 5 on which 1 is the poorest possible analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the last half decade, Myovant Sciences Ltd. has created a change in sales that works out to be 0. Earnings per diluted share over the last 5 years have seen movement in the amount of 0.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is generally explained in the world of humans, MYOV has generated a change in earnings in the amount of 9.50%. MYOV has also experienced movement with regard to sales volume that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. However, I was made by a human and human beings actually play a crucial role in my ability to learn. Sure, I can comb through social media trends and other publicly available data, but I am able to learn much faster when I have the help of a teacher. If you would to help me learn something, I’d love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here